Heparin-associated thrombocytopenia (HAT II) in a patient undergoing high dose chemotheraphy with consecutive stem cell-rescue;Heparin-induzierte thrombozytopenie Typ II im Rahmen einer hochdosis- chemotherapie mit anschliessender Stammzellrescue

Klinische Padiatrie

Volumn 210, Issue 3, 1998, Pages 102-105

  Sauer, Martin ^a   Gruhn, Bernd ^a   Fuchs, Dietlinde ^a   Altermann, Wolfgang ^b   Zintl, Felix ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Children; Danaparoid Sodium; Heparin; Heparin associated thrombocytopenia; Heparinoid

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DANAPAROID; DOXORUBICIN; HEPARIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; THIOTEPA; VINCRISTINE;

ADOLESCENT; ARTICLE; CANCER CHEMOTHERAPY; CASE REPORT; DRUG MEGADOSE; HUMAN; MALE; PAROTID GLAND TUMOR; RHABDOMYOSARCOMA; STEM CELL TRANSPLANTATION; THROMBOCYTOPENIA; THROMBOSIS;

EID: 0031949159     PISSN: 03008630     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1043859     Document Type: Article

References (32)

1. Adams, J. G., L. J. Humphrey, X. Zhang, D. Silver: Do patients with the heparin-induced thrombocytopenia syndrom have heparin-specific antibodies? J. Vasc. Surg. 21 (1995) 247-253
2. DeAlarcon, P. A., J. A. Schmieder, R. Gingrich, K. P. Klugman: Pattern of response colony-stimulating activity in the serum of patients undergoing bone marrow transplantation. Exp. Hematol. 16 (1988) 316-319
3. Amiral, J., F. Bridey, M. Wolf: Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases. Thromb. Haemost. 73 (1995) 21-28
4. Bertina, R. M., B. P. C. Koelemann, T. Koster, F. R. Rosendaal, R. J. Driven, H. de Ronde, P. A. van der Velden, P. H. Reitsma: Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369 (1994) 64-67
5. Chesebro, J. H., P. Zoldhelyl, L. Badimon, V. Fuster: Role of thrombin in arterial thrombosis: implications of therapy. Thromb. Haemost. 66 (1991) 1-5
6. Chong, B. H., M. C. Berndt: Heparin-induced thrombocytopenia. Blut 58 (1989) 53-57
7. Chong, B. H., H. N. Magnani: Orgaran in heparin-induced thrombocytopenia. Haemostasis 22 (1992) 85-91
8. Chong, B. H., J. Burgess, F. Ismail: The clinical usefulness of the platelet aggregation test for the diagnosis of heparin induced thrombocytopenia. Thromb. Haemost. 69 (1993) 344-350
9. Chong, B. H.: Heparin-induced thrombocytopenia. Br. J. Haematol. 89 (1995) 431-439
10. Fauser, A. A., L. Kanz, G. M. Sprull, G. W. Lohr: Megakaryocytic colony-stimulating activity receiving a marrow transplantation during hematopoietic reconstitution. Transplantation 46 (1988) 543-547
11. Greengard, J. S., X. Sun, X. Xu, J. A. Férnandez, J. H. Griffin, B. Evatt: Activated protein C resistance caused by Arg 506 Gln mutation in factor Va. Lancet 343 (1994) 1361-1362
12. Greinacher, A., C. Mueller-Eckhardt: Diagnostik der Heparin-assoziierten Thrombozytopenie. Dtsch. Med. Wschr. 116 (1991) 1479-1482
13. Greinacher, A., I. Michels, V. Kiefel, C. Mueller-Eckhardt: A rapid and sensitive test for diagnosing heparin-associated thrombocytopenia. Thromb. Haemost. 66 (1991) 734-736
14. Greinacher, A., I. Michels, M. Schaefer: Heparin associated thrombocytopenia with polysulphated chondroitine sulphate: Evidence for immunological cross-reactivity between heparin and polysulphated glycosaminoglycan. Br. J. Haematol. 81 (1992) 252-254
15. Greinacher, A., J. Amiral, V. Dummel, A. Vissac, V. Kiefel, C. Mueller-Eckhardt: Laboratory diagnosis of heparin-associated thrombocytopenia and comparison of platelet aggregation test, heparin induced platelet activation test and platelet factor 4/heparin ELISA. Transfusion 34 (1994) 381-385
16. Greinacher, A., B. Pötsch, J. Amiral, V. Dummel, A. Eichner, C. Mueller-Eckhardt: Heparin-associated thrombocytopenia: isolation of the antibody and characterization of the multimolecular PF-4 complex as the major antigen. Thromb. Haemost. 71 (1994) 247-251
17. Harenberg J., R. Malsch, L. Piazolo, D. L. Heene: Analysis of heparin binding to human leukocytes using a fluorescein-5-isothiocyanate labeled heparin fragment. Cytometry 23 (1996) 59-66
18. Johnson P. H.: Hirudin: Clinical potention of a thrombin inhibitor. Annu. Rev. Med. 45 (1994) 165-177
19. Kelton J. G., J. W. Smith, T. E. Warkentin: Immunoglobulin G from patients with heparin-induced thrombocytopenia binds to a complex of heparin and platelet factor 4. Blood 83 (1994) 3232-3239
20. King, D. J., J. G. Kelton: Heparin associated thrombocytopenia. Ann. Intern. Med. 100 (1984) 535-540
21. Magnani H. N.: Heparin-induced thrombocytopenia (HIT): An overview of 23 patients treated with Orgaran (Org 10172). Thromb. Haemost. 70 (4) (1993) 554-561
22. Marbet, G. A., M. Verstraete, J. Kienast et al.: Clinical pharmacology of intravenously administered recombinant desulfatohirudin (CGP 39 393) in healthy volunteers. J. Cardiovasc. Pharm. 22 (1993) 364-372
23. Parent F., F. Bridey, M. Dryfus, D. Musset et al.: Treatment of venous thromboembolism with intravenous hirudin (HBV 023): an open pilot study. Thromb. Haemost. 70 (3) (1993) 386-388
24. Pötzsch B., C. Unkrig, K. Madlener, A. Greinacher, G. Müller-Berghaus: APC-RESISTANCE and early onset of oral anticoagulation are high thrombotic risk factors in patients with heparin-associated thrombocytopenia (HAT). Ann. of Hematology 72 Suppl I (1996) A6
25. Rhodes G., R. Dixon, D. Silber: Heparin-induced thrombocytopenia with thrombotic and hemorrhagic manifestations. Surg. Gynecol. Obstet. 136 (1973) 409-416
26. Storb, R., E. D. Thomas, C. D. Buchner: Allogeneic marrow grafting for treatment of aplastic anemia. Blood 43 (1974) 137-180
27. Storb, R., E. D. Thomas, P. L. Weiden: Aplastic anemia treated by allogeneic bone marrow transplantation: a report on 49 new cases from Seattle. Blood 48 (1976) 817-841
28. Tezcan, A. Z., H. Tezcan, D. A. Gastineau, J. O Armitage, W. D. Haire: Heparin-induced thrombocytopenia after bone marrow transplantation: report of two cases. Bone Marrow Transplantation 14 (1994) 487-490
29. Visentin G. P., S. E. Ford, J. P. Scott, R. H. Aster: Antibodies from patient with heparin-inducedthrombocytopenia/Thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells. J. Clin. Invest. 93 (1994) 81-88
30. Voorberg J., J. Roelse, R. Koopman, H. Büller, F. Berends, J. W. ten Cate, K. Mertens, J. A. van Mourik: Association of thromboembolism with single point-mutation at ARG (506) of factor V. Lancet 343 (1994) 1535-1536
31. Warkentin, T. E. J. G. Kelton: Heparin-induced thrombocytopenia. Ann. Rev. Med. 40 (1989) 31-44
32. Warkentin, T. E., M. N. Levine, J. Hirsh: Heparin-induced thrombocytopenia in patients treated with low-molecular-weight-heparin or unfractionated heparin. N. Engl. J. Med. 332 (1995) 1330-1335